thiazolyl blue has been researched along with sri 62-834 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lohmeyer, M; Workman, P | 2 |
2 other study(ies) available for thiazolyl blue and sri 62-834
| Article | Year |
|---|---|
Lack of enantio-selectivity in the in vitro antitumour cytotoxicity and membrane-damaging activity of ether lipid SRI 62-834: further evidence for a non-receptor-mediated mechanism of action.
Topics: Antineoplastic Agents; Azepines; Cell Death; Cell Membrane; Furans; Humans; Phospholipid Ethers; Platelet Aggregation Inhibitors; Stereoisomerism; Tetrazolium Salts; Thiazoles; Triazoles; Tumor Cells, Cultured | 1992 |
The role of intracellular free calcium mobilization in the mechanism of action of antitumour ether lipids SRI 62-834 and ET18-OMe.
Topics: Antineoplastic Agents; Calcium; Cell Membrane; Dose-Response Relationship, Drug; Furans; Humans; Phospholipid Ethers; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1993 |